Metastatic Urothelial Cancer Treatments Continue to Gravitate Towards Immunotherapy and Targeted Therapies
A Yale Cancer Center expert offers a quick glance at the metastatic urothelial cancer treatment landscape.
A Yale Cancer Center expert offers a quick glance at the metastatic urothelial cancer treatment landscape.
The final breast cancer screening recommendation from the United States Preventive Services Task Force advises that women aged 40 should begin biennial screening.
An oncology nurse explains how her institution created a surgical path card that improved wait times and patient satisfaction in adults undergoing cancer surgery.
The implementation of a nurse navigator in a lymphedema program has helped patients with the condition obtain timely care, which can potentially improve outcomes.
In this episode of The Vitals, we speak with an expert who discussed the importance of supportive care and education for patients with lung cancer…
The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost…
Throughout April, the FDA approved drugs for the treatment of diseases including solid tumors, lung cancer, multiple myeloma, bladder cancer, and low-grade glioma.
The newly appointed president of the Oncology Nursing Society (ONS) discussed healthcare policies that she and ONS will continue to advocate for in the cancer…
Trastuzumab deruxtecan enhanced survival without disease progression compared with chemotherapy in HR-positive, HER2-low metastatic breast cancer after 1 or more lines of endocrine therapy.
From journaling to delegating everyday tasks, nurses can teach patients how to cope with treatment-related fatigue.
Trastuzumab-strf was approved for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or GEJ adenocarcinoma.